Shares of major European pharmaceutical firms declined on Friday after U.S. President Donald Trump sent letters to 17 global drugmakers demanding they align U.S. prices with those offered in other countries. The move follows a sweeping executive order signed earlier this year aimed at curbing high drug costs in the United States.
01 Aug 2025-13:44
